These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


121 related items for PubMed ID: 8672535

  • 21. GLP-1(7-36) amide stimulates insulin secretion in rat islets: studies on the mode of action.
    Fridolf T, Ahrén B.
    Diabetes Res; 1991 Apr; 16(4):185-91. PubMed ID: 1802486
    [Abstract] [Full Text] [Related]

  • 22. Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amide.
    Kolligs F, Fehmann HC, Göke R, Göke B.
    Diabetes; 1995 Jan; 44(1):16-9. PubMed ID: 7813808
    [Abstract] [Full Text] [Related]

  • 23. Glucagon-like peptide-1-(7-36)amide increases pulmonary surfactant secretion through a cyclic adenosine 3',5'-monophosphate-dependent protein kinase mechanism in rat type II pneumocytes.
    Benito E, Blazquez E, Bosch MA.
    Endocrinology; 1998 May; 139(5):2363-8. PubMed ID: 9564846
    [Abstract] [Full Text] [Related]

  • 24. Dual glucagon recognition by pancreatic beta-cells via glucagon and glucagon-like peptide 1 receptors.
    Moens K, Flamez D, Van Schravendijk C, Ling Z, Pipeleers D, Schuit F.
    Diabetes; 1998 Jan; 47(1):66-72. PubMed ID: 9421376
    [Abstract] [Full Text] [Related]

  • 25. Effects of glucagon-like peptide 1 (7-36) amide and glucagon on amylin release from perfused rat pancreas.
    Inoue K, Hisatomi A, Umeda F, Nawata H.
    Horm Metab Res; 1991 Sep; 23(9):407-9. PubMed ID: 1743611
    [Abstract] [Full Text] [Related]

  • 26. Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts.
    Zhao T, Parikh P, Bhashyam S, Bolukoglu H, Poornima I, Shen YT, Shannon RP.
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1106-13. PubMed ID: 16489128
    [Abstract] [Full Text] [Related]

  • 27. Exendin-4 agonist and exendin(9-39)amide antagonist of the GLP-1(7-36)amide effects in liver and muscle.
    Alcántara AI, Morales M, Delgado E, López-Delgado MI, Clemente F, Luque MA, Malaisse WJ, Valverde I, Villanueva-Peñacarrillo ML.
    Arch Biochem Biophys; 1997 May 01; 341(1):1-7. PubMed ID: 9143346
    [Abstract] [Full Text] [Related]

  • 28. Glucagon-like peptide-1(7-37) does not stimulate either hepatic glycogenolysis or ketogenesis.
    Murayama Y, Kawai K, Suzuki S, Ohashi S, Yamashita K.
    Endocrinol Jpn; 1990 Apr 01; 37(2):293-7. PubMed ID: 2171922
    [Abstract] [Full Text] [Related]

  • 29. Structure-activity relationships of glucagon-like peptide-1(7-36)amide: insulinotropic activities in perfused rat pancreases, and receptor binding and cyclic AMP production in RINm5F cells.
    Watanabe Y, Kawai K, Ohashi S, Yokota C, Suzuki S, Yamashita K.
    J Endocrinol; 1994 Jan 01; 140(1):45-52. PubMed ID: 8138751
    [Abstract] [Full Text] [Related]

  • 30. NFAT regulates insulin gene promoter activity in response to synergistic pathways induced by glucose and glucagon-like peptide-1.
    Lawrence MC, Bhatt HS, Easom RA.
    Diabetes; 2002 Mar 01; 51(3):691-8. PubMed ID: 11872668
    [Abstract] [Full Text] [Related]

  • 31. Reduced insulinotropic effects of glucagonlike peptide I-(7-36)-amide and gastric inhibitory polypeptide in isolated perfused diabetic rat pancreas.
    Suzuki S, Kawai K, Ohashi S, Mukai H, Murayama Y, Yamashita K.
    Diabetes; 1990 Nov 01; 39(11):1320-5. PubMed ID: 2146178
    [Abstract] [Full Text] [Related]

  • 32. Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes.
    Ebinger M, Jehle DR, Fussgaenger RD, Fehmann HC, Jehle PM.
    Am J Physiol Endocrinol Metab; 2000 Jul 01; 279(1):E88-94. PubMed ID: 10893327
    [Abstract] [Full Text] [Related]

  • 33. Inositolphosphoglycans possibly mediate the effects of glucagon-like peptide-1(7-36)amide on rat liver and adipose tissue.
    Márquez L, Trapote MA, Luque MA, Valverde I, Villanueva-Peñacarrillo ML.
    Cell Biochem Funct; 1998 Mar 01; 16(1):51-6. PubMed ID: 9580153
    [Abstract] [Full Text] [Related]

  • 34. The role of the free cytosolic calcium level in beta-cell signal transduction by gastric inhibitory polypeptide and glucagon-like peptide I(7-37).
    Lu M, Wheeler MB, Leng XH, Boyd AE.
    Endocrinology; 1993 Jan 01; 132(1):94-100. PubMed ID: 8380389
    [Abstract] [Full Text] [Related]

  • 35. Total parenteral nutrition-stimulated activity of inducible nitric oxide synthase in rat pancreatic islets is suppressed by glucagon-like peptide-1.
    Salehi A, Ekelund M, Lundquist I.
    Horm Metab Res; 2003 Jan 01; 35(1):48-54. PubMed ID: 12669271
    [Abstract] [Full Text] [Related]

  • 36. Protein kinase A-dependent stimulation of exocytosis in mouse pancreatic beta-cells by glucose-dependent insulinotropic polypeptide.
    Ding WG, Gromada J.
    Diabetes; 1997 Apr 01; 46(4):615-21. PubMed ID: 9075801
    [Abstract] [Full Text] [Related]

  • 37. Effects of truncated glucagon-like peptide-1 on pancreatic hormone release in normal conscious dogs.
    Kawai K, Suzuki S, Ohashi S, Mukai H, Murayma Y, Yamashita K.
    Acta Endocrinol (Copenh); 1990 Dec 01; 123(6):661-7. PubMed ID: 2284891
    [Abstract] [Full Text] [Related]

  • 38. [The entero-insular axis: the new incretin candidate glucagon-like peptide-1(7-36)amide (GLP-1(7-36))amide].
    Göke R, Göke B, Richter G, Arnold R.
    Z Gastroenterol; 1988 Nov 01; 26(11):715-9. PubMed ID: 2849249
    [Abstract] [Full Text] [Related]

  • 39. Amylin alters the biological action of the incretin hormone GLP-1(7-36)amide.
    Göke R, McGregor GP, Göke B.
    Life Sci; 1993 Nov 01; 53(17):1367-72. PubMed ID: 7692203
    [Abstract] [Full Text] [Related]

  • 40. GLP-I(7-36) amide augments Ba2+ current through L-type Ca2+ channel of rat pancreatic beta-cell in a cAMP-dependent manner.
    Suga S, Kanno T, Nakano K, Takeo T, Dobashi Y, Wakui M.
    Diabetes; 1997 Nov 01; 46(11):1755-60. PubMed ID: 9356022
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.